Hidetoshi Itani
Ise, 5168512, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Paradoxical Pyogenic Granuloma Associated With Ramucirumab but Not Bevacizumab: A Case Suggesting Differential Effects of VEGF Receptor and Ligand Inhibition.
Journal: Respirology case reports
Published: March 17, 2026
Inflammatory Biomarkers and Outcome Heterogeneity in Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Consecutive Cohort Study.
Journal: Advances in respiratory medicine
Published: March 12, 2026
Surgery-enabled precision oncology in an MSI-High pulmonary artery sarcoma with Lynch syndrome: a case report.
Journal: Frontiers in oncology
Published: March 04, 2026
Radiologically Evident Oesophageal Dilation in Paediatric Rumination Syndrome With Recurrent Aspiration Pneumonia: A Rare Case Without Achalasia.
Journal: Respirology case reports
Published: January 07, 2026
Palliative Osimertinib Rechallenge Achieving Rapid Improvement in Leptomeningeal Carcinomatosis After Prior Osimertinib-Induced ILD.
Journal: Respirology case reports
Published: December 07, 2025
Lorlatinib Achieved Rapid CNS Response in an 81-Year-Old NSCLC Patient With Performance Status Deterioration.
Journal: Respirology case reports
Published: July 28, 2025
Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 19, 2025
Dramatic Metabolic Response to Dual ICI With Chemotherapy in Low PD-L1 NSCLC Case.
Journal: Respirology case reports
Published: February 26, 2025
Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.
Journal: Clinical epigenetics
Published: January 21, 2025
Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.
Journal: Cancer treatment and research communications
Published: October 15, 2024
Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment.
Journal: Scientific reports
Published: May 17, 2024
Last Updated: 09/26/2026